Announced Thu, 2 Jul · 21:10 IST
Amendments to MOA and AOA, Authorized Capital raised to Rs. 10 Crore
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹81.26
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.4+12.6+17.1+26.5———
Up moveDown movePending
AI summary
Parmax Pharma has amended its MOA to raise authorized share capital from Rs. 6 Crore (60 lakh equity shares of Rs. 10) to Rs. 10 Crore (1 crore equity shares of Rs. 10). The company also adopted a new set of Articles of Association aligned with the Companies Act 2013. Both changes were approved by members at the EGM held on July 2, 2026.
Likely market impact
Higher authorized capital gives room for future fundraising, bonus, or stock split. No immediate effect on existing shareholders.